SCHEMBL22985863

SCHEMBL22985863

COc1cc(C(O)N2CCC(N3CCOCC3)CC2)ccc1Nc1nc(Nc2ccccc2S(=O)(=O)C(C)C)c2c(Cl)c[nH]c2n1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALK Q9UM73 14/20 0.63
▸ TTK P33981 3/20 0.55
▸ FES P07332 2/20 0.53
▸ FLT3 P36888 2/20 0.53
▸ LRRK2 Q5S007 2/20 0.53
▸ ZAP70 P43403 2/20 0.53
▸ INSR P06213 2/20 0.53
▸ FGFR1 P11362 2/20 0.53
▸ FGFR2 P21802 2/20 0.53
▸ FGFR4 P22455 2/20 0.53
▸ FGFR3 P22607 2/20 0.53
▸ MAP4K1 Q92918 2/20 0.53
▸ BMPR1B O00238 1/20 0.53
▸ PLK4 O00444 1/20 0.53
▸ STK25 O00506 1/20 0.53
▸ RIOK3 O14730 1/20 0.53
▸ CHEK1 O14757 1/20 0.53
▸ CASK O14936 1/20 0.53
▸ AURKA O14965 1/20 0.53
▸ GAK O14976 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18018792 0.87 LRRK2 (0.65) ALKTTKFESFLT3LRRK2
SCHEMBL22985886 0.86 LRRK2 (0.54) ALKTTKLRRK2INSREGFR
SCHEMBL22985891 0.85 LRRK2 (0.53) ALKTTKLRRK2INSREGFR
SCHEMBL18018791 0.83 LRRK2 (0.72) ALKTTKLRRK2MAP3K9MKNK2
SCHEMBL22985862 0.83 LRRK2 (0.65) ALKTTKLRRK2INSRIGF1R
SCHEMBL22985894 0.82 DYRK1A (0.52) ALKTTKLRRK2INSREGFR
SCHEMBL22985869 0.82 DYRK1A (0.52) ALKTTKLRRK2INSREGFR
SCHEMBL18018790 0.82 ALK (0.79) ALKTTKFESFLT3LRRK2
SCHEMBL22985920 0.81 LRRK2 (0.52) ALKTTKLRRK2INSREGFR
SCHEMBL22985916 0.75 ALK (0.48) ALKTTKFESFLT3LRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3778604-A1 LRRK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME Dana Farber Cancer Institute, Inc. (US) 2021-02-17 — — EP disclosed
EP-3778605-A2 LRRK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME Dana Farber Cancer Institute, Inc. (US) 2021-02-17 — — EP disclosed
Send feedback